Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Addition to Tretinoin in Acne
NCT02704507Unknown
- Sponsor
- Carilion Clinic
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of triamcinolone acetonide in acne vulgaris (2 arms), sponsored by Carilion Clinic. Primary endpoints: Change in subject-assessed itching and burning/stinging score at 8 weeks, Change in physician-assessed erythema score at 8 weeks and 2 more. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02704507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704507.